Member Info for Wilson63

Dog walk it's the only way to go, next stop r and d update.

Initially thoughts 101 mil cash fantastic

Respiratory Q4 mehh

Should have said January sales were very positive.

55% of sales outwith UK nice.

25 mil of cash should be on an accretive purchase sooner rather than later.

Byp good luck with your new strategy just don't use the board like a see saw.

Neilrich3 coprep has some form of data retention and to my shame I can't remember the exact words, I was that busy being nosy at the video of said product in the background, don't know if anyone else can help there.

*hat

409 more for me, never been a Billy big boots but this price is crazy, my hair s right in the middle of the ring, dog walk I think.

Hi Kaeren the top couple of tenders for India recently attracted my attention and antiques road show was on the tele at the time.

Tks to Tinyup and down
Just posted so what do people make of it

https://www.tendersontime.com/tenders/advanceSearch?q=Genesig/

Hey it's better than antiques road show.

Is February going to arrive a week early, if it does and with a bang I shall get well and truly inebriated.

As ever Tks Larry

https://mobile.twitter.com/larry64450205/status/1485301521453666307/photo/1

Tks B2 no doubt you are correct, I would have just preferred for logistical reasons that in remained here or Europe.

B2 what makes you think we are not the manufacturer? We designed it(I believe) I'd presume we assemble rather than manufacture. February should be interesting.

Chaps again totally get your frustration we need protecting so more rigorous verification required, they have a whole five people on it(think that's correct) but if they were already using lft's exempt from testing.

Laughable. Except it's serious, meanwhile PE runs an article on a company that has a significant bioinformatics ongoing programme.

Chaps I think like innova surescreen were already supplying and have therefore been granted the same " immunity" from the new more rigorous testing.

Lewis it's just a game they are playing, I'm sure he already knew, it's just a different avenue to try and push it out, it's done f all over the last two days so they have to try another poisonous avenue, imho of course.

Tks fb I'm sure we will be hearing lots from you now, don't know if my two brain cells can cope.

Hans yesterdays news already disproved as Tom kite taking one line and spouting around it, if I was a betting man whistleblower initials DH who has or will reappear on here shortly.

Well our hat is certainly on the ring on the diagnostics side as long as he ceo(I've only done this to play a great song)

https://www.google.co.uk/search?q=say+something+james&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari

Trouble is Bing007 you can't get on the board coz of ALL the disruptive.......(word of own choice)

Ooh look microgen one of the companies of our one trick pony on this report.

http://www.blackseagrain.net/2022/01/17/veterinary-test-kits-market-size-analysis-and-key-manufacturers-with-outlook-2022-2028-megacor-diagnostik-mercodia/

Tks to conqueror.

Jean Pierre's credentials, handy if anybody breaks down

One of the founders of Novacyt in July 2006.
30 years in the car and electrical components industry (various functions/M&A/business restructuring).
Of which 10 years Outside France: Singapore, North America, Belgium and Italy.

David Allmond
Chief Executive Officer

Appointed CEO of Novacyt in 2021
Over 25 years of global experience in pharmaceuticals & biopharmaceutical companies
Internationally experienced, strategic business leader with strong track record in global commercialisation
Built & led multiple diverse, successful teams in dynamic growth companies including Amgen, Celgene & Amryt Pharma
C-level executive with AIM and NASDAQ listed companies

That's Global Commercialisation for any interlopers tick tock. 2022 the year of the rebound.